What are KORU Medical Systems's total assets?

KORU Medical Systems (KRMD) holds $28.6M in total assets, up 5.1% year over year.

How much debt does KORU Medical Systems have?

KORU Medical Systems carries $3.5M in total debt against $16.9M of shareholders' equity, a debt-to-equity ratio of 0.21.

How much cash does KORU Medical Systems have?

KORU Medical Systems holds $8.8M in cash and equivalents.

Can KORU Medical Systems cover its short-term obligations?

Its current ratio is 2.33 — current assets exceed current liabilities.

Where does KORU Medical Systems's balance sheet data come from?

Every line is extracted from KORU Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

KORU Medical Systems KRMD Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q2 '26	Q1 '26	Q4 '25	Q3 '25	Q2 '25
Cash and cash equivalents	——	$8.77M+0.4%	$8.87M-7.4%	$8.46M-3.9%	$8.05M-23.0%
Accounts receivable, net	——	$5.98M+0.6%	$3.7M+2.8%	$5.41M+4.8%	$4.93M-15.7%
Inventories	——	$4.48M+36.5%	$3.68M+31.1%	$4.41M+12.3%	$3.95M+52.5%
Raw materials	——	——	$732.51K-11.5%	——	——
Finished goods	——	——	$2.95M+49.0%	——	——
Prepaid expenses and other current assets	——	$1.03M+43.8%	$908.54K+21.2%	$1.03M+7.7%	$486.52K+2.9%
Total current assets	——	$20.59M+8.4%	$19.99M+4.5%	$19.42M+2.6%	$17.58M-9.2%
Property and equipment, net	——	$4.34M-4.4%	$4.47M+4.2%	$4.24M-6.9%	$4.37M+18.8%
Accumulated depreciation	——	$4.21M+14.8%	$4.07M+17.1%	$4.05M+21.2%	$3.86M+23.2%
Operating lease right-of-use assets	——	$2.86M-0.4%	$2.96M-0.3%	$2.67M-12.9%	$2.77M-18.9%
Intangible assets, net	——	$711.21K-0.7%	$684.84K-6.2%	$681.62K-8.7%	$698.97K-6.2%
Other non-current assets	——	$98.97K0.0%	$98.97K0.0%	$98.97K-82.9%	$98.97K-82.9%
Allowance for credit losses	——	——	$694.28K-2.5%	——	——
Total assets	——	$28.59M+5.1%	$28.2M+3.6%	$27.1M-1.0%	$25.52M-6.5%
Accounts payable	——	$2.64M+30.9%	$2.27M+37.4%	$1.87M+12.1%	$1.09M-31.4%
Accrued expenses	——	$385.89K-62.8%	$531.97K-34.4%	$456.07K-40.5%	$688.94K+55.1%
Current portion of long-term debt	——	$126.32K+7.9%	$124.91K+8.1%	$120.21K+5.2%	$118.65K+5.3%
Operating lease liabilities, current	——	$421.73K+4.2%	$413.45K+3.3%	$413.49K+4.4%	$409.02K+4.4%
Finance Lease Liability, Current	——	$126.32K+7.9%	$124.91K+8.1%	$120.21K+5.2%	$118.65K+5.3%
Total current liabilities	——	$8.85M+13.5%	$8.19M+13.8%	$7.83M+23.9%	$6.05M+17.8%
Operating lease liabilities, non-current	——	$2.77M-4.4%	$2.88M-4.0%	$2.69M-13.3%	$2.79M-12.8%
Finance Lease Liabilities (Total)	——	$172.88K—	$203.59K-36.0%	——	——
Operating Lease Liabilities (Total)	——	$3.19M—	$3.29M-3.2%	——	——
Finance lease liabilities	——	$46.56K-73.3%	$78.68K-61.2%	$116.28K-49.5%	$145.47K-43.9%
Total liabilities	——	$11.67M+7.3%	$11.15M+7.2%	$10.64M+10.2%	$8.99M+4.5%
Common stock	——	75M0.0%	75M0.0%	75M0.0%	75M0.0%
Additional paid-in capital	——	$54.8M+9.0%	$52.45M+5.8%	$51.38M+5.0%	$50.66M+4.8%
Retained earnings	——	-$32.82M-7.5%	-$32.02M-9.0%	-$31.53M-13.3%	-$30.75M-17.2%
Treasury stock	——	$5.55M+42.9%	$3.88M0.0%	$3.88M0.0%	$3.88M0.0%
Total stockholders' equity	——	$16.92M+3.5%	$17.05M+1.4%	$16.46M-7.2%	$16.53M-11.6%
Total liabilities and stockholders' equity	——	$28.59M+5.1%	$28.2M+3.6%	$27.1M-1.0%	$25.52M-6.5%
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)	——	$8.77M+0.4%	$8.87M-7.4%	$8.46M-3.9%	$8.05M-23.0%
Other Inventory, Net	——	——	$4.02K+0.9%	——	——
Other Receivables	——	$335.21K+4.4%	$319.96K+15.4%	$103.08K+38.7%	$161.19K—
Deferred Tax Assets and Other Non-Current Assets	——	$98.97K0.0%	$98.97K+206,088%	$98.97K0.0%	$98.97K0.0%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	$65.62K0.0%	——	——
Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)	——	——	$360.01K-11.5%	——	——
Indefinite-Lived Research and Development Assets	——	——	$1.28M-47.9%	——	——
Net Investment in Lease	——	$2.86M-0.4%	$2.96M-0.3%	$2.67M-12.9%	$2.77M-18.9%
Intangible assets — net	——	$711.21K-0.7%	$684.84K-6.2%	$681.62K-8.7%	$698.97K-6.2%
Operating lease right-of-use assets	——	$2.86M-0.4%	$2.96M-0.3%	$2.67M-12.9%	$2.77M-18.9%
Other non-current assets	——	$98.97K0.0%	$98.97K0.0%	$98.97K0.0%	$98.97K0.0%
Property, plant and equipment at cost	——	$8.55M+4.2%	$8.54M+10.0%	$8.28M+5.0%	$8.23M+20.8%
Operating Lease Right-of-Use Assets in Other Assets	——	$2.86M-0.4%	$2.96M-0.3%	$2.67M-12.9%	$2.77M-18.9%
Software and Technology Licenses, Net	——	$98.97K0.0%	$98.97K0.0%	$98.97K0.0%	$98.97K0.0%
Accrued Manufacturing Costs	——	$385.89K-62.8%	$531.97K-34.4%	$456.07K-40.5%	$688.94K+55.1%
Other Commercial Liabilities	——	$5.27M+32.5%	$4.83M+23.1%	$4.63M+65.9%	$3.64M+69.5%
Accrued Liabilities, Current	——	$5.27M+32.5%	$4.83M+23.1%	$4.63M+65.9%	$3.64M+69.5%
Compensation and benefits	——	$385.89K-62.8%	$531.97K-34.4%	$456.07K-40.5%	$688.94K+55.1%
Other accrued liabilities	——	$11.07K-89.9%	$27.72K-5.3%	$2.89K-98.4%	$104.1K-76.8%
Lease Liability Payments - 2021	——	$98.58K—	$131.44K0.0%	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	$554.48K—	$554.48K+3.8%	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	$553.76K—	$553.76K+6.3%	——	——
Lease Liability Payments - Due Year Two	——	$74.19K—	$74.19K-43.6%	——	——
Lease Liability Payments - Due Year Three	——	$557.29K—	$557.29K+4.4%	——	——
Lease Liability Payments - Due Year Four	——	$553.76K—	$553.76K+6.3%	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	$451.49K—	$539.33K+1.0%	——	——
Operating Lease Liability Payments - 2026 (Lessee)	——	$557.29K—	$557.29K+4.4%	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	$568.22K—	$557.29K+4.4%	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	$553.76K—	$553.76K+6.3%	——	——
Operating Lease Liability Payments - 2029 (Lessee)	——	$568.22K—	——	——	——
Lease Liability Payments - Due After Year Five	——	$986.16K—	——	——	——
Operating Lease Liability Payments - Thereafter (Lessee)	——	$986.16K—	——	——	——
Total debt	——	$3.49M-2.8%	$3.62M-5.6%	$3.34M-15.6%	$3.47M-15.0%
Common Stock Par Value Per Share	——	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common Stock Shares Issued	——	49.9M+0.8%	49.8M+0.8%	49.7M+0.9%	49.7M+0.8%
Additional paid-in capital	——	$54.8M+9.0%	$52.45M+5.8%	$51.38M+5.0%	$50.66M+4.8%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	——	$499.34K+0.8%	$497.91K+0.8%	$497.14K+0.9%	$496.56K+0.8%
Treasury Stock, Value	——	$5.55M+42.9%	$3.88M0.0%	$3.88M0.0%	$3.88M0.0%
Cumulative Cost Basis	——	$8.55M+4.2%	$8.54M+10.0%	$8.28M+5.0%	$8.23M+20.8%
Cash and cash equivalents, end of period	——	$8.77M+0.4%	$8.87M-7.4%	$8.46M-3.9%	$8.05M-23.0%
Common stock, par value (in dollars per share)	——	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	——	$75M0.0%	$75M0.0%	$75M0.0%	$75M0.0%
Common stock, shares issued (in shares)	——	$49.93M+0.8%	$49.79M+0.8%	$49.71M+0.9%	$49.66M+0.8%
Common Stock, Shares, Outstanding	——	$46.13M0.0%	$46.37M+0.9%	$46.29M+1.0%	$46.23M+0.9%
Deferred Tax Assets Credits	——	——	$113.2K-12.6%	——	——
Deferred Tax Assets Deferred Lease Liability	——	——	$830.8K+28.3%	——	——
Deferred Tax Assets, Gross	——	——	$8.42M+1.2%	——	——
Deferred Tax Assets, Net of Valuation Allowance	——	——	$1.36M+10.2%	——	——
Deferred Tax Assets Net Operating Loss	——	——	$4.98M+23.8%	——	——
Deferred Tax Assets NQO And RSA Stock Options	——	——	$517.42K+47.6%	——	——
Temporary differences related to Texas Margin Tax	——	——	$694.28K-2.5%	——	——
Deferred Tax Liabilities, Net	——	——	$1.36M+10.2%	——	——
Deferred Tax Liabilities Fixed Assets	——	——	-$553.23K+13.5%	——	——
Deferred Tax Liabilities Intangibles	——	——	-$61.6K-5.9%	——	——
Deferred Tax Liabilities ROU Assets	——	——	-$747.41K-38.8%	——	——
Federal Research Credit Carryforward	——	——	$113.2K-12.6%	——	——
Current maturities of long-term debt	——	$126.32K+7.9%	$124.91K+8.1%	$120.21K+5.2%	$118.65K+5.3%
2027	——	$98.58K—	$131.44K0.0%	——	——
Finance Lease Liability Payments Due Year Three	——	$6.18K—	$6.18K-91.7%	——	——
Finance Lease Liability Payments Due Year Two	——	$74.19K—	$74.19K-43.6%	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	——	$545.3K—	$527.95K+15.1%	$510.6K+15.7%	$493.24K+16.4%
2028	——	——	$65.62K-0.5%	——	——
2030	——	——	$65.62K0.0%	——	——
2031	——	——	$62K+4.0%	——	——
2027	——	——	$65.97K-1.2%	——	——
2029	——	——	$65.62K0.0%	——	——
Finite Lived Intangible Assets Amortization Expense After Year Five	——	——	$360.01K-11.5%	——	——
Interest Rate	——	5.5%—	——	——	——
Work-in-process and raw materials	——	——	$732.51K-11.5%	——	——
Finance leases	——	4.8%-1.6%	4.7%-1.6%	6.6%+0.3%	6.5%+0.2%
Lessee Financing Lease Imputed Interest	——	$6.07K—	$8.22K-67.2%	——	——
Lessee Financing Lease Lease Liability Payments Due Total	——	$178.95K—	$211.81K-38.3%	——	——
Lessee Operating Lease Discount Rate	——	$0.04-36.3%	$0.04-36.7%	$0.06-3.0%	$0.06-2.7%
Lessee Operating Lease Imputed Interest	——	$478.55K—	$466.56K-16.1%	——	——
Lessee Operating Lease Liability Payments Due After Year Four	——	——	$1.55M-15.2%	——	——
Lessee Operating Lease Liability Payments Due Total	——	$3.67M—	$3.76M-5.0%	——	——
Net Operating Loss Carryforwards Federal	——	——	$22.51M+22.9%	——	——
Net Operating Loss Carryforwards State And Local	——	——	$4.39M+24.3%	——	——
Other receivables	——	$335.21K+4.4%	$319.96K+15.4%	$103.08K+38.7%	$161.19K—
Prepaid expenses	——	$1.03M+43.8%	$908.54K+21.2%	$1.03M+7.7%	$486.52K+2.9%
State Research Credit Carryforward	——	——	$0—	——	——
Treasury stock, shares (in shares)	$4.02M+16.9%	$3.44M0.0%	$3.44M0.0%	$3.44M0.0%	$3.44M+0.5%
Treasury Stock Preferred Shares	——	3.8M+11.1%	3.4M0.0%	3.4M0.0%	3.4M0.0%
Weighted-Average Discount Rate	——	4.1%-2.3%	4.1%-2.4%	6.4%-0.2%	6.4%-0.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about KORU Medical Systems.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are KORU Medical Systems's total assets?: KORU Medical Systems (KRMD) holds $28.6M in total assets, up 5.1% year over year.
How much debt does KORU Medical Systems have?: KORU Medical Systems carries $3.5M in total debt against $16.9M of shareholders' equity, a debt-to-equity ratio of 0.21.
How much cash does KORU Medical Systems have?: KORU Medical Systems holds $8.8M in cash and equivalents.
Can KORU Medical Systems cover its short-term obligations?: Its current ratio is 2.33 — current assets exceed current liabilities.
Where does KORU Medical Systems's balance sheet data come from?: Every line is extracted from KORU Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.